As of June 7, 2025, Nanovibronix Inc (NAOV) reports a EV/EBITDA of -0.69.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Nanovibronix Inc's EV/EBITDA to Peers
To better understand Nanovibronix Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Nanovibronix Inc (NAOV) | -0.69 |
| Intuitive Surgical Inc (ISRG) | 64.79 |
| Dexcom Inc (DXCM) | 41.92 |
| Boston Scientific Corp (BSX) | 39.50 |
| IDEXX Laboratories Inc (IDXX) | 33.84 |
| Stryker Corp (SYK) | 32.95 |
Compared to its competitors, Nanovibronix Inc's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.